Status:

UNKNOWN

Analgesic Efficacy of Capsaicin 8% Patch (QUTENZA®) in Coccygodygnia

Lead Sponsor:

Nantes University Hospital

Conditions:

Coccyx Disorder

Eligibility:

All Genders

Brief Summary

A retrospective study over a period of 6 years to explore analgesic efficacy of 8% Capsaicin patch (QUTENZA®) in coccygodynic patients, as well as neuropathic predictive factors of therapeutic respons...

Detailed Description

Coccygodynia corresponds to a localized pain in the coccyx region, aggravated or triggered by sitting and/or by getting up from a seat. Even if there is no epidemiology of this pain in France, coccygo...

Eligibility Criteria

Inclusion

  • Patients who received topical Capsaicin 8% patch therapy for the treatment of their coccygodygnia between August 2016 and August 2022

Exclusion

  • Patients who have already received 8% Capsaicin patch topical treatment in coccyx area.

Key Trial Info

Start Date :

August 15 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 21 2023

Estimated Enrollment :

106 Patients enrolled

Trial Details

Trial ID

NCT05983263

Start Date

August 15 2023

End Date

December 21 2023

Last Update

August 9 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.